FPR A14 Catalog No.:M22082-C on the pharmacokinetics of a

on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women

without affecting the basal specific binding to rat brain membranes

novel series of potent matrix metalloproteinase inhibitors with antitumour activity

3-benzodiazol-1-yl]but-2-en-1-yl]-2-(1-ethyl-3-methyl-1H-pyrazole-5-amido)-7-methoxy-1H-1

it was subsequently removed from the market in 2007 due to FDA concerns about possible adverse cardiovascular effects

FPR A14 Catalog No.:M22082-C on the pharmacokinetics of aProduct information CAS Number: 329691 12 5 Molecular Weight: 404. 42 Formula: C23H20N2O5 Chemical Name: N' [(1Z) [4 (benzyloxy) 3 methoxyphenyl]methylidene] 2H 1,3 benzodioxole 5 carbohydrazide Smiles: COC1=CC( C=N\NC(=O)C2C=C3OCOC3=CC=2)=CC=C1OCC1C=CC=CC=1 InChiKey: ULOKADSYVZOTTL CFRMEGHHSA N InChi: InChI=1S C23H20N2O5 c1 27 21 11 17(7 9 19(21)28 14 16 5 3 2 4 6 16)13 24 25 23(26)18 8 10 20 22(12 18)30 15 29 20 h2 13H,14 15H2,1H3,(H,25,26) b24 13